Late left ventricular dysfunction after anatomic repair of congenitally corrected transposition of the great arteries

Victor Bautista-Hernandez1, Patrick O Myers2, Frank Cecchin3

  • 1Department of Cardiac Surgery, Children's Hospital Boston, Harvard Medical School, Boston, Mass; Department of Pediatric Cardiology, Children's Hospital Boston, Harvard Medical School, Boston, Mass.

Insights

Late left ventricular dysfunction after congenital heart repair is common, especially in older patients needing pacemakers. Early repair and cardiac resynchronization therapy may prevent this complication.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Congenital Heart Disease

Background:

  • Anatomic repair of congenitally corrected transposition of the great arteries (ccTGA) shows early success.
  • Late left ventricular dysfunction remains a significant concern after ccTGA repair.
  • Understanding risk factors and preventive strategies is crucial.

Purpose of the Study:

  • To identify factors contributing to late left ventricular dysfunction post-ccTGA repair.
  • To evaluate the impact of cardiac resynchronization therapy (CRT) as primary or secondary pacing.
  • To assess the efficacy of CRT in preventing or improving left ventricular function.

Main Methods:

  • Retrospective review of 106 patients with ccTGA undergoing anatomic repair (1992-2012).
  • Analysis of preoperative variables, surgical procedures, and postoperative outcomes.
  • Assessment of pacemaker implantation and cardiac resynchronization therapy (CRT) use.

Main Results:

  • 12% of patients developed moderate to severe left ventricular dysfunction.
  • Older age at repair (>10 years), higher weight (>20 kg), pacemaker use, and neo-aortic regurgitation were associated with dysfunction.
  • CRT, particularly as an upgrade, improved left ventricular function in most patients; primary CRT precluded dysfunction.

Conclusions:

  • Late left ventricular dysfunction is a notable risk after ccTGA repair, particularly in older patients and those requiring pacemakers.
  • Early anatomic repair combined with CRT for indicated patients may prevent the onset of left ventricular dysfunction.
  • CRT appears to be a promising strategy for preserving or improving cardiac function post-ccTGA repair.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.7K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812